Cargando…
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma
Lymphoma is one of the most common cancers in adolescents and young adults, but historically, this population has had lower clinical trial enrollment and improvements in overall survival as compared to other age populations. There are multiple challenges that are unique to this population that have...
Autores principales: | Toner, Keri, Allen, Carl E., Jain, Shweta, Kahl, Brad, Leonard, John, Wasserstrom, Heather, Friedberg, Jonathan W., Seibel, Nita L., Kelly, Kara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660108/ https://www.ncbi.nlm.nih.gov/pubmed/38024612 http://dx.doi.org/10.1002/jha2.787 |
Ejemplares similares
-
Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023) -
Mature B‐cell lymphomas in adolescents and young adults
por: El‐Mallawany, Nader Kim, et al.
Publicado: (2023) -
Lymphoma in adolescents and young adults: Navigating a path forward together
por: Evens, Andrew M., et al.
Publicado: (2023) -
The pathobiology of select adolescent young adult lymphomas
por: Steidl, Christian, et al.
Publicado: (2023) -
Scientific techniques in adolescent and young adult classic Hodgkin lymphoma
por: Maura, Francesco, et al.
Publicado: (2023)